Cost Analysis of Personalized Intensive Lifestyle Modification for NCD Risk Populations in Thailand
Keywords:
Cost analysis, Health promotion, Lifestyle coaching, Non-communicable diseases, Personalized intensive lifestyle modificationAbstract
Background: Non-communicable diseases (NCDs) remain the leading cause of morbidity, mortality, and healthcare expenditure in Thailand, yet real-world cost evidence for personalized intensive lifestyle interventions is limited. Objective: To estimate the cost of implementing the Personalized Intensive Lifestyle Modification Program (PILM) for populations at risk of NCDs in Thailand. Methods: A cross-sectional retrospective cost analysis was conducted using an activity-based costing approach from the provider perspective. Fiscal year 2023 cost data were collected from 12 service settings (hospitals, municipal health facilities, and public institutions). Core PILM components delivered across settings included baseline risk assessment, individualized lifestyle counseling/coaching, structured diet and physical activity planning, and continuous follow-up via face-to-face visits and digital communication. Costs were classified as labor, material, and capital. Unit cost per participant was calculated for a six-month program cycle and reported in U.S. dollars. Results: A total of 477 participants received PILM services across 12 settings. Labor accounted for 63% of total cost, followed by capital (29%) and material (8%). The mean unit cost was USD 83 per participant (range: USD 24.97–156.71). Conclusion: PILM implementation costs varied across settings, with labor as the primary cost driver. These findings support budgeting and service design for integrating personalized NCD prevention into Thailand’s universal health coverage.
References
World Health Organization. Global status report on noncommunicable diseases 2014. Geneva: World Health Organization; 2014.
Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011; 377(9775): 1438–47. DOI: 10.1016/S0140-6736(11)60393-0
World Health Organization. Noncommunicable diseases: key facts [Internet]. Geneva: World Health Organization; 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases. accessed: 25 March, 2025.
Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, et al. The global economic burden of noncommunicable diseases. Geneva: World Economic Forum; 2011.
Aekplakorn W, editor. National Health Examination Survey V (NHES V), 2014. Nonthaburi: Health Systems Research Institute; 2016. (In Thai)
Kontis V, Mathers CD, Rehm J, Stevens GA, Shield KD, Bonita R, et al. Contribution of six risk factors to achieving the 25×25 non-communicable disease mortality reduction target: a modelling study. Lancet. 2014; 384(9941): 427–37. DOI: 10.1016/S0140-6736(14)60616-4
Nocon M, Hiemann T, Müller-Riemenschneider F, Thalau F, Roll S, Willich SN. Association of physical activity with all-cause and cardiovascular mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil. 2008; 15(3): 239–46. DOI: 10.1097/HJR.0b013e3282f55e09
Mozaffarian D, Afshin A, Benowitz NL, Bittner V, Daniels SR, Franch HA, et al. Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association. Circulation. 2012; 126(12): 1514–63. DOI: 10.1161/CIR.0b013e318260a20b
Ministry of Public Health. Thailand National NCDs Strategy 2017–2021. Nonthaburi: Ministry of Public Health; 2017.
Pudpong N, Durier N, Suphanchaimat R, Seneerattanaprayul P. Assessing the role of village health volunteers in NCD prevention and control in Thailand. Trop Med Int Health. 2019; 24(3): 341–52. DOI: 10.1111/tmi.13197
Tangcharoensathien V, Chandrasiri O, Seubsman S, Kongklai A. Health promotion and disease prevention financing in Thailand: lessons for low- and middle-income countries. Health Promot Int. 2011; 26(Suppl 2): ii83–ii90. DOI: 10.1093/heapro/dar032
Vongmongkol V, Limwattananon S, Tangcharoensathien V, Prakongsai P. Monitoring and evaluating progress towards universal health coverage in Thailand. PLoS Med. 2014; 11(9): e1001726. DOI: 10.1371/journal.pmed.1001726
World Health Organization. Best practices in noncommunicable disease prevention and control: Thailand. Geneva: World Health Organization; 2021.
Topol EJ. Individualized medicine from prewomb to tomb. Cell. 2014; 157(1): 241–53. DOI: 10.1016/j.cell.2014.02.012
Diabetes Prevention Program Research Group. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care. 2012; 35(4): 723–30. DOI: 10.2337/dc11-1468
Puska P, Vartiainen E, Tuomilehto J, Salomaa V, Nissinen A. Changes in premature deaths in Finland: successful long-term prevention of cardiovascular diseases. JAMA. 1998; 277(11): 955–62. PMID: 9803593
Aekplakorn W, Porapakkham Y, Taneepanichskul S. The effectiveness of a lifestyle intervention program to prevent type 2 diabetes in Thai adults: a community-based randomized controlled trial. Diabetes Care. 2011; 34(7): 1609–14. DOI: 10.2337/dc10-2244
Amornwichet P, Pannarunothai S, Srithamrongsawat S. Cost-effectiveness analysis of diabetes prevention program in Khon Kaen province, Thailand. J Med Assoc Thai. 2010; 93(7): 838–47.
Wongsin U, Chiangchaisakulthai K, Suppradist W, Samiphuk N, Pongpattrachai D, Wannasri A, et al. A health promotion program for improving weight, body mass index, and body composition among individuals with non-communicable diseases in Thailand: a RE-AIM model and financial feasibility study. J Health Res. 2023; 17:1–12. DOI: 10.61768/jhsr.v17i3.2748
Bank of Thailand. Financial market statistics [Internet]. Bangkok: Bank of Thailand; 2025. Available from: https://www.bot.or.th/en/statistics/financial-market-statistics.html. accessed: 7 April, 2025.
Okubo R, Kondo M, Hoshi SL, Okada M, Doi M, Takahashi H, et al. Cost-effectiveness of behavior modification intervention for patients with chronic kidney disease in the FROM-J study. J Ren Nutr. 2021; 31(5): 484–93. DOI: 10.1053/j.jrn.2020.12.00822.
Jacobs-van der Bruggen MAM, van Baal PH, Hoogenveen RT, Feenstra TL, Briggs AH, Lawson K, et al. Cost-effectiveness of lifestyle modification in diabetic patients. Diabetes Care. 2009; 32(8): 1453–8. DOI: 10.2337/dc09-0363
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Creative Commons License CC-BY-ND
